Revolution Medicines, Inc. (RVMD) FY2025 Annual Balance Sheet
As of 2025-12-31
Balance Sheet
As of 2025-12-31
Swipe to see the full flow
Chart details
Revolution Medicines, Inc. (RVMD) FY2025 Annual Balance Sheet
Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 2,354,508,000 US dollars
- Current assets
- 2,075,037,000 US dollars
- Non-current assets
- 279,471,000 US dollars
- Liabilities
- 723,211,000 US dollars
- Current liabilities
- 290,424,000 US dollars
- Non-current liabilities
- 432,787,000 US dollars
- Equity
- 1,631,297,000 US dollars
- Marketable securities
- 1,641,934,000 US dollars
- Cash and cash equivalents
- 383,745,000 US dollars
- Prepaid expenses and other current assets
- 49,358,000 US dollars
- Operating lease right-of-use asset
- 132,084,000 US dollars
- Intangible assets, net
- 55,800,000 US dollars
- Property and equipment, net
- 33,194,000 US dollars
- Long-term deposits
- 24,148,000 US dollars
- Other noncurrent assets
- 14,779,000 US dollars
- Goodwill
- 14,608,000 US dollars
- Restricted cash
- 4,858,000 US dollars
- Accrued expenses and other current liabilities
- 209,340,000 US dollars
- Accounts payable
- 64,616,000 US dollars
- Operating lease liability, current
- 16,468,000 US dollars
- Liability related to the sale of future royalties
- 268,446,000 US dollars
- Operating lease liability, noncurrent
- 142,234,000 US dollars
- Warrant liability
- 18,546,000 US dollars
- Deferred tax liability
- 2,353,000 US dollars
- Other noncurrent liabilities
- 1,208,000 US dollars
- Additional paid-in capital
- 4,497,143,000 US dollars
- Accumulated other comprehensive income
- 3,237,000 US dollars
- Common stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 197,001,401 and 185,896,625 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively
- 19,000 US dollars
- Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively; none issued and outstanding at December 31, 2025 and December 31, 2024, respectively
- 0 US dollars
- Accumulated deficit
- negative 2,869,102,000 US dollars
- Gross equity (calculated)
- 4,500,399,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
